E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers A > Headlines for Alexza Pharmaceuticals, Inc. > News item
Published on 9/21/2006 in the Prospect News Biotech Daily.

JMP keeps Alexza at market outperform

Alexza Pharmaceuticals, Inc. was reiterated at market outperform by JMP Securities analyst Charles C. Duncan following the analyst's San Francisco bus tour. The company is on track for significant milestones in the second half of 2006 and possibly a partnership, according to the analyst. Shares of the Palo Alto, Calif.-based development-stage company were unchanged at $7.00. (Nasdaq: ALXA)


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.